8-KFiled Aug 16, 8:00 PM ET
Ispire Technology Appoints Steven Przybyla as President
$ISPR · Ispire Technology Inc.Research Summary
AI-generated summary of this SEC filing
Ispire Technology Appoints Steven Przybyla as President
What Happened
- On August 11, 2026, Ispire Technology Inc. (ISPR) announced that its board appointed Steven Przybyla as President, effective immediately. He will continue to serve as the company’s Chief Legal Officer and Secretary, roles he has held since September 1, 2023.
- Mr. Przybyla, age 40, brings over 10 years of regulated cannabis industry experience and nearly a decade of nicotine/tobacco regulatory experience; his background includes helping secure the only FDA Modified Risk Tobacco Product (MRTP) approval for a combustible cigarette while at 22nd Century Group.
Key Details
- Appointment effective: August 11, 2026; press release furnished under Regulation FD on August 17, 2026.
- Employment agreement: Przybyla Agreement dated June 25, 2024; employment is at‑will.
- Compensation disclosed: $400,000 annual base salary (may be increased but not decreased), eligible for an annual discretionary bonus with a 50% target, and standard executive benefits (health, 401(k)); company will pay for professional license maintenance.
- Severance and equity: If terminated without cause or if he resigns for good reason, he is entitled to 12 months’ then‑applicable base salary and immediate accelerated vesting of 50% of any unvested equity grants under the Company’s 2022 Equity Incentive Plan.
- No family relationships with other executives or required related‑party transactions were reported.
Why It Matters
- The appointment consolidates leadership responsibilities (President + Chief Legal Officer + Secretary) and highlights management continuity. The filing provides concrete compensation and severance terms investors can use to assess potential cash and equity-related obligations.
- Mr. Przybyla’s regulatory experience, including work on an FDA MRTP approval, is a factual credential investors may consider when evaluating the company’s capability to navigate regulation in cannabis and nicotine/tobacco markets.